Your browser doesn't support javascript.
loading
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
Chawla, Akhil; Qadan, Motaz; Castillo, Carlos Fernandez-Del; Wo, Jennifer Y; Allen, Jill N; Clark, Jeffrey W; Murphy, Janet E; Catalano, Onofrio A; Ryan, David P; Ting, David T; Deshpande, Vikram; Weekes, Colin D; Parikh, Aparna; Lillemoe, Keith D; Hong, Theodore S; Ferrone, Cristina R.
Affiliation
  • Chawla A; Division of Surgical Oncology, Department of Surgery, Northwestern Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Qadan M; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Castillo CF; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wo JY; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Allen JN; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Clark JW; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Murphy JE; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Catalano OA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ryan DP; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ting DT; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Deshpande V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Weekes CD; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Parikh A; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lillemoe KD; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ferrone CR; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ann Surg ; 276(5): e502-e509, 2022 11 01.
Article in En | MEDLINE | ID: mdl-33086310
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2022 Document type: Article Country of publication: Estados Unidos